Speaker illustration

Professor Hyun-Jai Cho

Seoul National University Hospital, Seoul (Korea (Republic of))

Member of:

European Society of Cardiology

The role of latrophilin-2 in maintaining cardiac cell-to-cell junctions and its implications for dilated cardiomyopathy and sudden death

Event: ESC Congress 2023

Topic: Heart Failure

Session: Cardiomyopathies/Channelopathies

Thumbnail

Impact of early initiation of mTOR inhibitors on long-term survival outcome after heart transplantation: data from the nationwide Korean Organ Transplant Registry (KOTRY)

Event: Heart Failure 2023

Topic: Heart Transplantation

Session: ePosters in chronic heart failure - treatment 2

Thumbnail

Sequential stimulation and inhibition of lysophosphatidic acid receptor 4 are critical for cardiac differentiation and repair

Event: ESC Congress 2019

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Mitochondria and lipids in the heart

Thumbnail

ADGRL2 is an essential surface molecule for cardiac lineage specification and heart development

Event: ESC Congress 2019

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Insights into cardiac cell biology for repair and regeneration

Thumbnail

Hazardous effects of widespread inotrope use in acute heart failure patients

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Comparison of characteristics and 3-year outcomes in patients with acute heart failure with preserved, mid-range, and reduced ejection fraction

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Acute heart failure – Epidemiology, prognosis, outcome

Thumbnail

Identification of Latrophilin-2, a novel receptor that specifies cardiac progenitor cells from pluripotent stem cells and is essential for heart development

Event: ESC Congress 2018

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Best Posters in heart and vascular development

Thumbnail

Comparison of Characteristics and 3-Year Outcomes in Patients with Acute Heart Failure with Preserved, Mid-range, and Reduced Ejection Fraction

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb